Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

341 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
IRDye800CW labeled uPAR-targeting peptide for fluorescence-guided glioblastoma surgery: Preclinical studies in orthotopic xenografts.
Kurbegovic S, Juhl K, Sørensen KK, Leth J, Willemoe GL, Christensen A, Adams Y, Jensen AR, von Buchwald C, Skjøth-Rasmussen J, Ploug M, Jensen KJ, Kjaer A. Kurbegovic S, et al. Among authors: von buchwald c. Theranostics. 2021 May 21;11(15):7159-7174. doi: 10.7150/thno.49787. eCollection 2021. Theranostics. 2021. PMID: 34158842 Free PMC article.
Intraoperative Sentinel Lymph Node Evaluation: Implications of Cytokeratin 19 Expression for the Adoption of OSNA in Oral Squamous Cell Carcinoma.
Shaw R, Christensen A, Java K, Maddani RE, Liloglou T, Asterios T, von Buchwald C, Wessel I, Kiss K, Kjaer A, Lelkaitis G, Long A, Risk J, Robinson M. Shaw R, et al. Among authors: von buchwald c. Ann Surg Oncol. 2016 Nov;23(12):4042-4048. doi: 10.1245/s10434-016-5337-6. Epub 2016 Jul 8. Ann Surg Oncol. 2016. PMID: 27393570 Free PMC article.
uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: proof-of-concept in orthotopic xenograft model.
Christensen A, Juhl K, Persson M, Charabi BW, Mortensen J, Kiss K, Lelkaitis G, Rubek N, von Buchwald C, Kjær A. Christensen A, et al. Among authors: von buchwald c. Oncotarget. 2017 Feb 28;8(9):15407-15419. doi: 10.18632/oncotarget.14282. Oncotarget. 2017. PMID: 28039488 Free PMC article.
Urokinase-type plasminogen activator receptor (uPAR), tissue factor (TF) and epidermal growth factor receptor (EGFR): tumor expression patterns and prognostic value in oral cancer.
Christensen A, Kiss K, Lelkaitis G, Juhl K, Persson M, Charabi BW, Mortensen J, Forman JL, Sørensen AL, Jensen DH, Kjaer A, von Buchwald C. Christensen A, et al. Among authors: von buchwald c. BMC Cancer. 2017 Aug 25;17(1):572. doi: 10.1186/s12885-017-3563-3. BMC Cancer. 2017. PMID: 28841839 Free PMC article.
341 results